The IQVIA Institute for Human Data Science

Evidence-based insights for healthcare

The IQVIA Institute for Human Data Science contributes to the advancement of human health globally through timely research, insightful analysis and scientific expertise applied to granular non-identified patient-level data.
Subscribe to the IQVIA Institute
Be among the first to hear about research and activities

Latest Reports

Download the latest Institute reports

Video Player is loading.
Current Time 0:00
Duration 11:58
Loaded: 0%
Stream Type LIVE
Remaining Time 11:58
 
1x
    • Chapters
    • descriptions off, selected
    • subtitles off, selected
    • en (Main), selected

    Global Trends in R&D 2025: Video brief

    Hear from IQVIA Institute lead authors as they walk through key findings in each chapter of this annual trend report including funding, trial activity, drug approvals and launches, development productivity, and productivity enablers.
    Video Player is loading.
    Current Time 0:00
    Duration 7:04
    Loaded: 0%
    Stream Type LIVE
    Remaining Time 7:04
     
    1x
      • Chapters
      • descriptions off, selected
      • subtitles off, selected
      • en (Main), selected

      Watch video

      2025 Indicators of Progress for the Life Sciences Sector

      View all of the IQVIA Institute's Upcoming and On-Demand Events

      Trending

      Annual Reports on Latest Trends

      The Global Use of Medicines

      Learn about spending and usage of medicines in the past year and outlook to the future, globally and across specific therapy areas and countries.

      Global Trends in R&D

      Discover trends in drug approvals and launches, pipeline activity, and data on clinical trial activity.

      The Use of Medicines in the U.S.

      Examine the state of the U.S. health system, medicine usage, drug pricing, and costs for patients.

      Global Oncology Trends

      Explore research and development in oncology and the progress being made to improve representativeness of race and ethnicity in clinical trial populations.

      Contact Us